{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:19:17Z","timestamp":1787761157893,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025077","name":"University of Ottawa Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.modpat.2026.101030","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:24:59Z","timestamp":1781911499000},"page":"101030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coexistent Endometrial and Fallopian Tube Carcinoma: Molecular and Pathological Features for Risk Stratification"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6430-3607","authenticated-orcid":false,"given":"Kianoosh","family":"Keyhanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabath Priya","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanner","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harman","family":"Sekhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Greenstreet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Grondin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.modpat.2026.101030_bib1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMc2035378","article-title":"Endometrial cancer","volume":"384","author":"Lu","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.modpat.2026.101030_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-pathol-020117-043609","article-title":"Molecular genetics of endometrial carcinoma","volume":"14","author":"Bell","year":"2019","journal-title":"Annu Rev Pathol"},{"issue":"7447","key":"10.1016\/j.modpat.2026.101030_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.modpat.2026.101030_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41379-021-00963-y","article-title":"Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience","volume":"35","author":"Devereaux","year":"2022","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101030_bib5","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41416-023-02141-0","article-title":"Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry","volume":"128","author":"Vermij","year":"2023","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2026.101030_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100085","article-title":"Grade and estrogen receptor expression identify a subset of no specific molecular profile endometrial carcinomas at a very low risk of disease-specific death","volume":"36","author":"Jamieson","year":"2023","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101030_bib7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/his.15241","article-title":"The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile","volume":"85","author":"Alafraidi","year":"2024","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.modpat.2026.101030_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.6004\/jnccn.2025.0038","article-title":"NCCN Guidelines\u00ae insights: uterine neoplasms, version 3.2025","volume":"23","author":"Abu-Rustum","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.modpat.2026.101030_bib9","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101030_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1097-0142(19820701)50:1<163::AID-CNCR2820500131>3.0.CO;2-K","article-title":"Simultaneous presentation of carcinoma involving the ovary and the uterine corpus","volume":"50","author":"Eifel","year":"1982","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101030_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0046-8177(85)80210-0","article-title":"Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases","volume":"16","author":"Ulbright","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.101030_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.gore.2018.12.009","article-title":"Synchronous carcinomas of endometrium and ovary: a pragmatic approach","volume":"27","author":"Blake Gilks","year":"2019","journal-title":"Gynecol Oncol Rep"},{"issue":"2","key":"10.1016\/j.modpat.2026.101030_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ygyno.2004.05.006","article-title":"Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases","volume":"94","author":"Soliman","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101030_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2018.10.033","article-title":"Risk-based stratification of carcinomas concurrently involving the endometrium and ovary","volume":"152","author":"Turashvili","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101030_bib15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ijc.32907","article-title":"Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome","volume":"147","author":"Reijnen","year":"2020","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101030_bib16","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e7","article-title":"Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma","volume":"30","author":"Yoneoka","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101030_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv427","article-title":"Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas","volume":"108","author":"Schultheis","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.modpat.2026.101030_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.modpat.2026.101030_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.modpat.2026.101030_bib20","series-title":"Endometrioid Carcinoma of the Ovary","article-title":"WHO Classification of Tumours. Female genital tumours","year":"2020"},{"key":"10.1016\/j.modpat.2026.101030_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2024.04.016","article-title":"Prognostic performance of the 2023 FIGO staging schema for endometrial cancer","volume":"187","author":"Matsuo","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2026.101030_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.102832","article-title":"Role of adjuvant therapy de-escalation for low-grade endometrioid endometrial cancer with adnexal only metastasis: call for research","author":"Erfani","year":"2026","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.modpat.2026.101030_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101957","article-title":"Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity","volume":"35","author":"Jamieson","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2026.101030_bib24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PAT.0b013e328360b6e7","article-title":"Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis","volume":"45","author":"Stewart","year":"2013","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.modpat.2026.101030_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.pgp.0000179614.47838.82","article-title":"Transtubal spread of serous adenocarcinoma of the endometrium: an underrecognized mechanism of metastasis","volume":"25","author":"Snyder","year":"2006","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101030_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/gyno.1999.5415","article-title":"The significance of adnexal involvement in endometrial carcinoma","volume":"74","author":"Connell","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101030_bib27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.pas.0000209839.00467.05","article-title":"Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases","volume":"30","author":"Culton","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101030_bib28","doi-asserted-by":"crossref","first-page":"djv158","DOI":"10.1093\/jnci\/djv158","article-title":"Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG Oncology\/Gynecologic Oncology Group 210 Trial","volume":"107","author":"Felix","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.modpat.2026.101030_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115686","article-title":"ENDOESTRO score: where is the dark side? Evaluation of estrogen receptor expression cutoff in endometrial cancer molecular classification, an ambispective study","volume":"227","author":"Perrone","year":"2025","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101030_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(25)00612-6","article-title":"Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial","volume":"27","author":"van den Heerik","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.modpat.2026.101030_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.humpath.2020.12.003","article-title":"The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study","volume":"109","author":"van Weelden","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.101030_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2024.10.028","article-title":"Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer","volume":"192","author":"Vrede","year":"2025","journal-title":"Gynecol Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:25:13Z","timestamp":1787757913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0893395226000736"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101030","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coexistent Endometrial and Fallopian Tube Carcinoma: Molecular and Pathological Features for Risk Stratification","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101030"}}